BioSpace News Archive

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today reported that on February 1, 2021,

Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 743,495, common shares of the Company (the “Common Shares”), at a price

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore” ) announces a non-brokered private placement of up to 7,000,000 units (" Units ") at a price of $0.22 per unit for gross proceeds of $1,540,000. (the " Private Placement "). The proceeds will be used for general working capital purposes. “We’ve built a strong business development program poised for significant growth across multiple business lines,” Said Hector B

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced the pricing of its initial public offering of 6,250,000 shares of common stock at the public offering price of $16.00 per share, for total gross proceeds of $100 million

In response to winter storm Orlena, the governor of New Jersey has declared a state-wide state of emergency. Blue Cross Blue Shield of Massachusetts (Blue Cross), Inc. is expediting access to care for members who may be affected.

In response to post-wildfire landslides, also known as debris flows, the governor of California has declared a state of emergency for Monterey , Santa Cruz , and San Luis Obispo counties . Blue Cross Blue Shield of Massachusetts (Blue Cross), Inc. is expediting access to care for members who may be affected.

The release dated January 25, 2021, contained a clerical error: the date of the planned release of the financial results for the fourth quarter and year ended December 31, 2020, should have been Thursday, February 25, 2021 (instead of Wednesday, February 24, 2021) and the date of the conference call to discuss the results should have been February 26, 2021 (instead of February 25, 2021). The corrected release reads: Extendicare Announces

Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, announced the pricing of its upsized initial public offering of 7,000,052 shares of common stock at a public offering price of $19.00 per share.

New study shows that Molecular Partners’ tri-specific antiviral DARPin® candidates, ensovibep (MP0420) and the Company’s preclinical candidate, MP0423, remain therapeutically active against the known mutations of SARS-CoV-2 including those present in the United Kingdom (UK) and South Africa (SA) variants